Trials / Completed
CompletedNCT04378842
COVID-19 and ICU-acquired MDR Bacteria
Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 368 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.
Detailed description
Multicenter observational before-after study, aiming to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to MDR bacteria.
Conditions
Timeline
- Start date
- 2020-05-18
- Primary completion
- 2021-07-26
- Completion
- 2021-07-26
- First posted
- 2020-05-07
- Last updated
- 2022-10-05
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04378842. Inclusion in this directory is not an endorsement.